Lactose Intolerance – Market outlook, Epidemiology, Competitive Landscape and Market Forecast Report – 2020 To 2030
Lactose intolerance is an impaired ability to digest lactose, a sugar found in milk and other dairy products.
Etiology-
Lactose intolerance in
infants (congenital lactase deficiency) is caused by mutations in the LCT gene.
The LCT gene provides instructions for making the lactase enzyme. LCT gene expression is controlled by a DNA
sequence called a regulatory element, which is located within a nearby gene
called MCM6.
Epidemiology-
In the Americas, the
prevalence estimates ranged from 36% in the USA to 80% in Colombia.
The competitive landscape of Lactose
Intolerance includes country-specific approved as well as pipeline therapies.
Any asset/product-specific designation or review and Accelerated Approval are
being tracked and supplemented with analyst commentary.
KOLs
insights of Lactose Intolerance across 8 MM market from the centre of
Excellence/ Public/ Private hospitals participated in the study. Insights
around current treatment landscape, epidemiology, clinical characteristics,
future treatment paradigm, and Unmet needs.
Lactose
Intolerance Market Forecast: Patient Based Forecast Model (MS. Excel Based
Automated Dashboard) which Data Inputs with sourcing, Market Event, and Product
Event, Country specific Forecast Model, Market uptake and patient share uptake,
Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario,
Summary, and Insights.
S. No Asset Company Stage
1 RP-G28 Ritter
Pharmaceuticals, Inc. Phase 3
Comments
Post a Comment